Long acting highly selective beta agonsts can are can be used for monotherapy of mild asthma as they accumulate in high concentrations in the membrane of bronchial smooth muscle cells and exert longer action..
Althought the mechanism of actiono is correct, long acting beta-agonists should not be used as monotherapy as they do not affect inflammation component of asthma.